Browsing by Author Leung, LKS

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 9 of 9
TitleAuthor(s)Issue DateViews
 
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong
Journal:PharmacoEconomics - Open
Loong, HHFWong, CKHLeung, LKSDhankhar, PInsinga, RPChandwani, SHsu, DCLee, MYKHuang, MPellissier, JRai, AAchra, MTan, SC
2020
118
 
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong
Journal:Cost Effectiveness and Resource Allocation
Loong, HHWong, CKHLeung, LKSChan, CPKChang, AZhou, ZYXie, JGibbs, M
2020
44
 
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong
Journal:Cost Effectiveness and Resource Allocation
Loong, HHWong, CKHLeung, LKSTan, SCJen, JLee, MYKAguiar-Ibáñez, RWang, J
2020
83
 
Cost-effectiveness of ceritinib in previously untreated ALK-positive advanced non-small cell lung cancer in Hong Kong
Proceeding/Conference:ESMO Asia Congress
Loong, HHFWong, CKHLeung, LKSChan, CPKChang, AGibbs, M
2018
52
 
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong
Proceeding/Conference:Annals of Oncology
Loong, HHFWong, CKHLeung, LKSLeung, MTKWang, JStevinson, K
2016
84
 
Neutrophil-lymphocyte and platelet-lymphocyte ratios as robust prognostic markers in sarcomas: A population-based analysis of 3746 sarcoma patients from Hong Kong
Proceeding/Conference:Annals of Oncology
Kwan, SCSWong, CKHHo, CWZhang, YZTse, TLau, YMLeung, LKSTan, TLoong, H
2019
26
 
Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas
Journal:ESMO Open
Loong, HHFWong, CKHWei, YKwan, SSCZhang, YTse, TLau, YMLeung, LKSTang, GCH
2020
59
 
Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong
Proceeding/Conference:Annals of Oncology
Loong, HHFWong, CKHHo, CWTse, TKwan, SSCLau, YMLeung, LKS
2019
35
 
Prevalence of chemotherapy use and its impact on overall survival in patients with bone and soft tissue sarcomas: A population-based analysis of 3746 patients
Proceeding/Conference:Annals of Oncology
Loong, HHFWong, CKHHo, CWLeung, LKSTse, TKwan, SSLau, YM
2019
35
Showing results 1 to 9 of 9